IMA
Price
$5.95
Change
-$0.04 (-0.67%)
Updated
Jun 23, 03:56 PM (EDT)
Capitalization
66.21M
45 days until earnings call
Intraday BUY SELL Signals
PVLA
Price
$117.88
Change
-$0.96 (-0.81%)
Updated
Jun 23, 04:08 PM (EDT)
Capitalization
1.7B
51 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMA vs PVLA

IMA vs PVLA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
IMA vs. PVLA commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMA is a Hold and PVLA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 23, 2026
Stock price -- (IMA: $5.87 vs. PVLA: $118.84)
Brand notoriety: IMA and PVLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMA: 21% vs. PVLA: 97%
Market capitalization -- IMA: $66.21M vs. PVLA: $1.7B
IMA [@Biotechnology] is valued at $66.21M. PVLA’s [@Biotechnology] market capitalization is $1.7B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMA’s FA Score shows that 1 FA rating(s) are green whilePVLA’s FA Score has 1 green FA rating(s).

  • IMA’s FA Score: 1 green, 4 red.
  • PVLA’s FA Score: 1 green, 4 red.
According to our system of comparison, both IMA and PVLA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMA’s TA Score shows that 5 TA indicator(s) are bullish while PVLA’s TA Score has 4 bullish TA indicator(s).

  • IMA’s TA Score: 5 bullish, 3 bearish.
  • PVLA’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, IMA is a better buy in the short-term than PVLA.

Price Growth

IMA (@Biotechnology) experienced а +5.96% price change this week, while PVLA (@Biotechnology) price change was +2.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

Reported Earning Dates

IMA is expected to report earnings on Aug 07, 2026.

PVLA is expected to report earnings on Aug 13, 2026.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PVLA($1.71B) has a higher market cap than IMA($66.2M). PVLA YTD gains are higher at: 13.538 vs. IMA (-14.928). PVLA has higher annual earnings (EBITDA): -42.66M vs. IMA (-53.41M). PVLA has more cash in the bank: 262M vs. IMA (117M). PVLA has less debt than IMA: PVLA (584K) vs IMA (2.42M). IMA (0) and PVLA (0) have equivalent revenues.
IMAPVLAIMA / PVLA
Capitalization66.2M1.71B4%
EBITDA-53.41M-42.66M125%
Gain YTD-14.92813.538-110%
P/E RatioN/A14.22-
Revenue00-
Total Cash117M262M45%
Total Debt2.42M584K414%
FUNDAMENTALS RATINGS
PVLA: Fundamental Ratings
PVLA
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
13
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMAPVLA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 8 days ago
88%
Bearish Trend 14 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
IMA
Daily Signal:
Gain/Loss:
PVLA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
LNGX40.750.82
+2.06%
Global X U.S. Natural Gas ETF
ZAPR26.59-0.01
-0.04%
Innovator Equity Dfnd Prt ETF -1 Yr Apr
FOCT52.15-0.08
-0.15%
FT Vest US Equity Buffer ETF Oct
NPV11.38-0.03
-0.26%
Nuveen Virginia Quality Municipal Income Fund
CUT27.80-0.17
-0.62%
Invesco MSCI Global Timber ETF

IMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMA has been closely correlated with CELC. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if IMA jumps, then CELC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMA
1D Price
Change %
IMA100%
-2.17%
CELC - IMA
78%
Closely correlated
+2.47%
SLXN - IMA
62%
Loosely correlated
-0.73%
MNOV - IMA
28%
Poorly correlated
-0.76%
RNAZ - IMA
21%
Poorly correlated
+6.38%
PVLA - IMA
7%
Poorly correlated
+5.08%
More

PVLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PVLA has been loosely correlated with DRMA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if PVLA jumps, then DRMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PVLA
1D Price
Change %
PVLA100%
+5.08%
DRMA - PVLA
42%
Loosely correlated
+5.13%
VIR - PVLA
41%
Loosely correlated
+4.48%
IOVA - PVLA
38%
Loosely correlated
+3.84%
ARQT - PVLA
37%
Loosely correlated
+1.76%
SEPN - PVLA
35%
Loosely correlated
-3.70%
More